Literature DB >> 527883

Bile acid clearance in liver disease.

L K Luey, K W Heaton.   

Abstract

The disappearance of intravenously administered cholylglycine-14C was studied in the fasting and postprandial states in seven subjects with healthy livers and 10 patients with liver disease. In neither group was there any significant difference in the pattern of 14C disappearance. In another 10 patients with liver disease there was no significant change when a loading dose of cholylglycine was given orally two hours beforehand. Clearance of bile acids seems to be unimpaired in all except severe liver disease. The apparent deterioration in endogenous bile acid removal after meals may be due simply to the increased amount of bile acids which are in circulation and available for portosystemic shunting.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527883      PMCID: PMC1412827          DOI: 10.1136/gut.20.12.1083

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Diagnositic value of serum bile acid estimations in liver disease.

Authors:  S Barnes; G A Gallo; D B Trash; J S Morris
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease.

Authors:  B Thjodleifsson; S Barnes; A Chitranukroh; B H Billing; S Sherlock
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

Review 3.  The enterohepatic circulation of bile acids in man.

Authors:  A F Hofmann
Journal:  Clin Gastroenterol       Date:  1977-01

4.  Factors affecting plasma clearance of (14C) cholic acid in patients with cirrhosis.

Authors:  M D Kaye; J E Struthers; J S Tidball; E DeNiro; F Kern
Journal:  Clin Sci Mol Med       Date:  1973-08

5.  Serum bile acid concentrations in patients with liver disease.

Authors:  O Fausa; E Gjone
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

6.  Serum bile acids in the diagnosis of hepatobiliary disease.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

7.  Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease.

Authors:  I T Gilmore; R P Thompson
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

8.  Determinants of fasting and postprandial serum bile acid levels in healthy man.

Authors:  N F LaRusso; N E Hoffman; M G Korman; A F Hofmann; A E Cowen
Journal:  Am J Dig Dis       Date:  1978-05

9.  Serum bile acid concentration after a test meal.

Authors:  O Fausa
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

10.  Evaluation of fluorimetrically estimated serum bile acid in liver disease.

Authors:  T Osuga; K Mitamura; F Mashige; D Imai
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

View more
  3 in total

1.  Endogenous bile acid tolerance test for liver function.

Authors:  M van Blankenstein; M Frenkel; J W van den Berg; F J ten Kate; E P Bosman-Jacobs; A C Touw-Blommesteyn
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

2.  Profiles of serum bile acids in liver diseases.

Authors:  M J Kim; D J Suh
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

3.  Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection.

Authors:  Li-Ting Yan; Li-Li Wang; Jia Yao; Ya-Ting Yang; Xiao-Rong Mao; Wei Yue; Yong-Wu Mao; Wei Zhou; Qing-Feng Chen; Yu Chen; Zhong-Ping Duan; Jun-Feng Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.